About Sofgen Pharma Join our Newsletter Contact
About Us

We are part
of Sofgen Pharma®

Sofgen CDMO® is part of Sofgen Pharma®, a leading integrated healthcare and pharmaceutical group dedicated to the development and manufacturing of pharmaceutical and nutraceutical solutions.

With a strong international footprint, Sofgen Pharma operates directly in 13 countries across the Americas while our B2B business extends our reach to more than 50 countries worldwide.

Sofgen Pharma softgel capsules
Softgel capsule

A Diversified, Integrated
Pharmaceutical Group

Sofgen Pharma's operations span the full pharmaceutical value chain, with expertise across four core business areas.

Integrated CDMO

Integrated CDMO (iCDMO) services, supporting partners from development through commercialization.

B2B
Rx Products

Rx products, focused on high-value and specialized therapies.

OTC Products

OTC products, designed for accessibility, quality, and consumer trust.

Diabetics Solutions

Diabetics solutions, addressing chronic-care needs with innovative approaches.

B2C

Built for Innovation and Scalable Growth

Our business model is anchored in strategic pillars that drive long-term growth and differentiation:

Innovation and R&D are at the core of Sofgen Pharma's culture. Backed by a team of 300+ scientists, technicians, and skilled professionals, and a portfolio of 500+ formulations, we develop an average of 150+ new products per year, including 50+ first-time launches annually over the past three years.

Sofgen Pharma operates 7 manufacturing facilities across the United States and Latin America, including the first FDA-approved pharmaceutical plant in South and Central America. This integrated regional presence enables operational synergies, speed to market, and reliable supply to over 50 global markets.

Our Rx and OTC portfolios are powered by proprietary delivery technologies, allowing us to develop differentiated, high-growth, and premium pharmaceutical solutions that meet evolving patient and consumer needs.

As part of Sofgen Pharma, Sofgen CDMO leverages this scale, expertise, and innovation ecosystem to deliver world-class development and manufacturing solutions to partners worldwide.

Global Presence

Corporate Global Footprint

6 extensive state-of-the-art manufacturing facilities and laboratories across America.

  • 1st FDA Approved Plant in LATAM for RX products.
  • One of the 5 Hormonal Softgel facilities in the world.
  • Centralized R+D Platform
Americas manufacturing footprint

Certified by leading regulatory entities worldwide

Australia
TGA Health Safety Regulation
Brasil
ANVISA
Canada
Health Canada / Santé Canada
Europa
MHRA
Mexico
COFEPRIS
Peru
DIGEMID
United States
BASC
United States
FDA
Colombia
 
Invima
 
Icontec ISO 13485
 
Icontec ISO 45001
 
Icontec ISO 14001
 
Icontec ISO 9001
 
OEA Operador Económico Autorizado

Who We Are

Sofgen CDMO is a global Softgel CDMO/CMO that offers end-to-end solutions in Softgel technologies from development throughout delivery for generics, prescription drugs, OTC and specialized nutraceuticals.

With our wide capabilities and broad manufacturing expertise, plus our client experience model  we are able to:

Softgel bottle with capsules

Launch brands and products in innovative softgel formats.

Globe in petri dish

Expand and introduce brands to new markets

Orange softgel capsule

Extend the lifecycle of a wide variety of products.

Looking for your ideal Softgel CDMO Partner?

TALK TO OUR EXPERTS
Family representing our purpose to transform lives

Our Purpose

Transforming lives by delivering health and wellness to our partners and patients, guided by quality, ethics and sustainable results.

Client Experience Model

Driven by our passion to offer positive experiences across each customer touchpoint we mix our deep softgel knowledge and expertise, our flexibility, our desire to develop customized products that exceed customers' expectations, mixed with  a relationship based on connectivity, trust and empathy.

With a comprehensive range of CDMO services in diverse technologies, designed to elevate any pharmaceutical project, we are focused on supporting customer needs and exceeding their expectations.

Colorful softgel capsules representing client experience

Why Sofgen CDMO®?

Microscope

50 years of deep pharmaceutical know-how combined with a collaborative approach that creates value for every client, product, and brand.

Hand holding patient/people

End-to-end partnership approach, focused on advancing the health of patients and consumers in key markets.

Softgel/capsule

Specialists in Softgel and advanced delivery technologies for Generics, Rx, OTC, and specialized Nutraceuticals.

Gear / delivery technology

A strong focus on advanced delivery technologies and innovative formats designed to enhance efficiency, product performance, and overall experience.

Check

A strong focus on advanced delivery technologies and innovative formats designed to enhance efficiency, product performance, and overall experience.

GMP Compilant

Strong and proven capabilities to develop high-impact products within a robust GMP-compliant environment.

Hand capsule

Efficient tech transfers with a time-to-market mindset.

Capsule

Advanced infrastructure for hormonal products and other complex oral modalities.

Capsule

Integrated development and manufacturing capabilities across multiple sites in Brasil and Colombia enabling scalability, reliability, and supply chain efficiency.

Engine User

Client-centered operating model built on flexibility, connectivity, trust, and empathy, with the ability to tailor solutions to each project.

Integrated
Softgel
Capabilities

Innovation in Softgel Drug Delivery & Extended manufacturing capabilities for proximity to our customers & prospect partners.

Procaps manufacturing facility in Barranquilla

Colombia

Barranquilla

Area: 35,200 m², of which approx 8,200 m² is manufacturing plant floor space.

Capacity:

  • Softgel: 400 million units
  • Farmix: 9 million units
  • Hormonal Products: 25 million units

Services: Softgel Technologies, Oral & Liquid solid dose manufacturing (tablets, powders syrups, suspensions), High Potent Compounds, Hormonal Products, Lab Services, Commercial Packaging, Product Development.

Colbras manufacturing facility in Cotia, Brazil

Brazil

Cotia

Area: 9,934 m², of which approx 5,569 m² is manufacturing plant floor space.

Capacity:

  • Softgel: 200 million units

Services: Softgel Technologies, Lab Services, Commercial Packaging, Product Development.